Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)
NCT01436578 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 273
Last updated 2015-07-07
Summary
This study will examine the safety and efficacy of posaconazole in general use in Korea.
Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
Conditions
- Fungal Infections
Interventions
- DRUG
-
Posaconazole oral suspension 40 mg/mL
Posaconazole oral suspension prescribed according to the current local label
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2013-11-30
- Completion
- 2013-11-30
More Related Trials
-
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)
NCT00034658 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
NCT00686543 ·Status: COMPLETED ·Phase: PHASE4
-
Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)
NCT00811642 ·Status: COMPLETED ·Phase: PHASE3
-
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)
NCT00034671 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)
NCT02387983 ·Status: COMPLETED ·Phase: PHASE1
-
Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)
NCT00686621 ·Status: APPROVED_FOR_MARKETING
-
Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)
NCT00034632 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
NCT02180165 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
NCT01782131 ·Status: COMPLETED ·Phase: PHASE3
-
Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication
NCT01680458 ·Status: COMPLETED
-
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
NCT03717623 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)
NCT00811928 ·Status: COMPLETED ·Phase: PHASE3
-
Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients
NCT05065658 ·Status: COMPLETED
-
Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)
NCT01777763 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of Voriconazole
NCT00942773 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients
NCT01419678 ·Status: COMPLETED ·Phase: NA
-
Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients
NCT03378479 ·Status: COMPLETED ·Phase: PHASE4
-
Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)
NCT04218851 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)
NCT00550732 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen
NCT03760276 ·Status: COMPLETED ·Phase: PHASE1
-
Diflucan Bioequivalence Study For Transferring The Manufacture
NCT03821480 ·Status: COMPLETED ·Phase: PHASE1
-
Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia
NCT04194086 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetic Study of Fluconazole in Premature Infants
NCT01683760 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea
NCT01073631 ·Status: COMPLETED
-
Posaconazole for Pulmonary Fungal Infection Prophylaxis in Hematopoietic Stem Cell Transplantation Patients
NCT04725942 ·Status: COMPLETED